What is the recommended treatment regimen for melasma, including photoprotection, topical agents, and systemic options?

Treatment for Melasma

Start with strict photoprotection and triple combination cream (hydroquinone 4%, tretinoin 0.05%, fluticasone 0.01%) as first-line therapy, as this remains the most effective evidence-based treatment for melasma. 1

First-Line Treatment Algorithm

Foundation: Photoprotection (Non-Negotiable)

• High-protection broad-spectrum sunscreen daily - this is mandatory for all patients regardless of other treatments chosen 2, 3
• Reapply every 2 hours during sun exposure
• Use physical barriers (hats, sun-protective clothing)
• Without photoprotection, all other treatments will fail

Primary Topical Therapy

Triple combination cream is superior to monotherapy and should be your initial prescription 1:

• Hydroquinone 4% + Tretinoin 0.05% + Corticosteroid (fluticasone or mometasone)
• Apply once daily at bedtime
• Treatment duration: 8-12 weeks initially
• This combination addresses multiple pathogenic mechanisms: melanin synthesis inhibition, epidermal turnover acceleration, and inflammation reduction

If triple combination unavailable or contraindicated, hydroquinone 4% monotherapy is the next best option 1

Treatment Period vs. Maintenance

The treatment approach must be divided into two distinct phases 3:

Active Treatment Phase (8-16 weeks):

• Triple combination cream or hydroquinone monotherapy
• Strict photoprotection
• Assess response at 8 weeks

Maintenance Phase (ongoing):

• Reduce frequency to 2-3 times weekly or switch to non-hydroquinone agents
• Continue photoprotection indefinitely
• This prevents the characteristically high recurrence rates

Second-Line Options for Inadequate Response

Alternative Topical Agents

If hydroquinone is ineffective, contraindicated, or causes irritation 3, 1:

• Azelaic acid 15-20%
• Kojic acid 1-4%
• Arbutin 1.5%
• Tranexamic acid topical formulations
• Vitamin C derivatives

These are generally less effective than hydroquinone but have better safety profiles for long-term use.

Systemic Therapy: Oral Tranexamic Acid

For moderate-to-severe or recurrent melasma, add oral tranexamic acid 1, 4:

• Dosing: 250 mg twice daily
• Duration: 8-12 weeks minimum
• This is the most promising systemic treatment with good evidence
• Critical caveat: Screen for thromboembolic risk factors before prescribing - contraindicated in patients with history of DVT/PE, stroke, hypercoagulable states, or active cardiovascular disease
• Monitor for side effects including menstrual irregularities

Procedural Interventions for Refractory Cases

When to Consider Procedures

• After 12-16 weeks of optimal topical therapy without adequate response
• For dermal-predominant melasma (confirmed by Wood's lamp examination)
• In combination with topicals, never as monotherapy

Evidence-Based Procedural Options

Chemical Peels 4, 1:

• Glycolic acid 20-70% or salicylic acid peels
• Perform cautiously in darker skin types (Fitzpatrick IV-VI) due to PIH risk
• Results are equal or inferior to topical hydroquinone
• Use as adjunct, not replacement

Microneedling 4:

• Can enhance topical penetration
• Lower PIH risk than lasers in darker skin
• Combine with topical depigmenting agents

Laser Therapy - Use with Extreme Caution 1, 5:

• High risk of post-inflammatory hyperpigmentation, especially in skin of color 3
• If used, prefer low-fluence picosecond or 1927-nm fractional thulium laser
• Only in experienced hands
• Always combine with aggressive topical therapy
• Consider laser-assisted drug delivery of depigmenting compounds 5

Special Considerations for Skin of Color

Patients with Fitzpatrick skin types IV-VI require modified approach 3:

• Higher risk of post-inflammatory hyperpigmentation with all procedures
• Start with lower concentrations of active ingredients
• Avoid aggressive peels and high-energy lasers
• Prioritize topical combination therapy
• If procedures necessary, use lowest effective settings

Refractory Melasma Protocol

For patients failing standard therapy after 16 weeks 2, 5:

1. Verify compliance with photoprotection and topical regimen
2. Confirm diagnosis - rule out other pigmentary disorders
3. Assess melasma subtype with Wood's lamp (epidermal vs. dermal vs. mixed)
4. Add oral tranexamic acid if not already prescribed
5. Consider combination approach:
   • Continue topical depigmenting agents
   • Add antioxidants (vitamin C, niacinamide)
   • Consider low-energy fractional laser with laser-assisted drug delivery 5
   • Platelet-rich plasma may have adjunctive benefit 2

Critical Pitfalls to Avoid

• Never use procedural treatments without concurrent topical therapy - recurrence rates approach 100%
• Never skip photoprotection counseling - this is the most common reason for treatment failure
• Avoid high-energy lasers in darker skin types - risk of worsening pigmentation exceeds benefit 3
• Don't promise permanent cure - melasma is chronic and relapsing; set realistic expectations
• Don't use hydroquinone continuously beyond 12-16 weeks without breaks - risk of ochronosis, though rare
• Screen for hormonal triggers - oral contraceptives, pregnancy, hormone replacement therapy may perpetuate disease

Treatment Selection Based on Disease Severity

Mild melasma: Photoprotection + hydroquinone monotherapy or triple combination cream

Moderate melasma: Photoprotection + triple combination cream + consider oral tranexamic acid

Severe/refractory melasma: Photoprotection + triple combination cream + oral tranexamic acid + selective procedural intervention (chemical peel or microneedling preferred over laser)

The key to success is combining strict photoprotection with topical depigmenting agents, maintaining realistic expectations about chronicity, and reserving procedures for carefully selected refractory cases. 3, 1